Normoxic re-oxygenation ameliorates end-organ injury after cardiopulmonary bypass

被引:5
|
作者
Peng, Yun-Wen [1 ]
Major, Terry [2 ]
Mohammed, Azmath [2 ]
Deatrick, Kristopher B. [2 ]
Charpie, John R. [1 ]
机构
[1] Univ Michigan, Sch Med, Dept Pediat, Div Pediat Cardiol, 1540 East Hosp Dr,11-740 CS Mott Childrens Hosp, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Sch Med, Dept Surg, Ann Arbor, MI USA
关键词
Cardiopulmonary bypass; Cardioplegic arrest; Normoxia; hyperoxia; Reperfusion; Renal injury; Brain injury; ACUTE KIDNEY INJURY; BRAIN-INJURY; OXIDATIVE STRESS; BIOMARKERS; MARKERS;
D O I
10.1186/s13019-020-01173-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background In a rabbit model of cardiopulmonary bypass (CPB) and cardioplegic arrest, we previously showed that hyperoxic myocardial reperfusion was associated with increased left ventricular (LV) systolic dysfunction and myocardial injury compared with normoxic reperfusion. The aim of this study was to evaluate in our experimental model the impact of post-CPB reperfusion conditions on other organs potentially vulnerable to ischemic injury such as the brain and kidney. Methods After 60 min of CPB, aortic cross-clamp, and cold cardioplegic arrest, rabbits were reperfused under hyperoxic or normoxic conditions for 120 min. Left ventricular systolic contractility (LV + dP/dt) and diastolic relaxation (LV -dP/dt) were continuously recorded, and end-organ injury was assessed by measuring circulating biomarkers specific for kidney (cystatin C and creatinine) and brain injury [S100B and neuron specific enolase (NSE)]. At completion of the protocol, kidney and brain tissues were harvested for measuring oxidant stress (OS), inflammation and apoptosis. Results Following aortic cross-clamp removal, rabbits exposed to normoxic reperfusion demonstrated preserved LV systolic and diastolic function compared with hyperoxic reperfusion (LV + dP/dt: 70 +/- 14% of pre-CPB vs. 36 +/- 21%, p = 0.018; LV -dP/dt: 72 +/- 36% of pre-CPB vs. 33 +/- 20%, p = 0.023). Similarly, CPB increased plasma creatinine, S100B and NSE that were significantly attenuated by normoxic reperfusion compared with hyperoxic reperfusion (creatinine: 4.0 +/- 0.5 vs. 7.1 +/- 0.8 mg/dL, p = 0.004; S100B: 4.0 +/- 0.8 vs. 6.7 +/- 1.0 ng/mL, p = 0.047; NSE: 57.7 +/- 6.8 vs. 101.3 +/- 16.1 pg/mL, p = 0.040). Furthermore, both kidney and brain tissues showed increased mRNA expression and activation of pathways for OS, inflammation, and apoptosis, that were reduced under normoxic compared with hyperoxic conditions. Conclusions Normoxic reperfusion ameliorates cardiac, renal and neural injury compared with hyperoxic reperfusion in an in vivo animal model of CPB and cardioplegic arrest. This protective effect of normoxic reperfusion may be due to a reduction in signaling pathways for OS, inflammation, and apoptosis.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Normoxic re-oxygenation ameliorates end-organ injury after cardiopulmonary bypass
    Yun-Wen Peng
    Terry Major
    Azmath Mohammed
    Kristopher B. Deatrick
    John R. Charpie
    Journal of Cardiothoracic Surgery, 15
  • [2] Does Cardiopulmonary Bypass Provide Adequate End-Organ Perfusion?
    Koprivanac, Marijan
    Aly, Ahmed
    Magruder, Jonathan
    Acker, Andrew
    Grim, Joshua
    Acker, Michael
    Cevasko, Marisa
    Desai, Nimesh
    CIRCULATION, 2020, 142
  • [3] Novel Strategy to Improve End-Organ Function With Pulsatile Cardiopulmonary Bypass
    Atluri, Pavan
    MacArthur, John W.
    CIRCULATION JOURNAL, 2012, 76 (05) : 1087 - 1088
  • [4] Nadir hematocrit during cardiopulmonary bypass: End-organ dysfunction and mortality
    Loor, Gabriel
    Li, Liang
    Sabik, Joseph F., III
    Rajeswaran, Jeevanantham
    Blackstone, Eugene H.
    Koch, Colleen G.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2012, 144 (03): : 654 - +
  • [5] NEUTROPHIL PHENOTYPE USED TO PREDICT END-ORGAN DYSFUNCTION FOLLOWING CARDIOPULMONARY BYPASS
    Tresselt, Erin
    Moreland, Jessica
    Hook, Jessica
    Patel, Parth
    CRITICAL CARE MEDICINE, 2021, 49 (01) : 199 - 199
  • [6] Review of Interleukin-6 and Cardiopulmonary Bypass-Related End-Organ Injury Along With the Potential for Mitigation With Tocilizumab
    Yu, Althena
    Amrute, Junedh M.
    Eghtesady, Pirooz
    WORLD JOURNAL FOR PEDIATRIC AND CONGENITAL HEART SURGERY, 2024,
  • [7] Brain injury as end-organ damage in hypertension
    Scuteri, Angelo
    LANCET NEUROLOGY, 2012, 11 (12): : 1015 - 1017
  • [8] Nicorandil attenuates ventricular dysfunction and organ injury after cardiopulmonary bypass
    Peng, Yun-Wen
    Major, Terry
    Deatrick, Kristopher B.
    Mohammed, Azmath
    Jeakle, Mark
    Charpie, John R.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2022, 368 : 62 - 68
  • [9] Pharmacogenomics and end-organ susceptibility to injury in the perioperative period
    Schwinn, Debra A.
    Podgoreanu, Mihai
    BEST PRACTICE & RESEARCH-CLINICAL ANAESTHESIOLOGY, 2008, 22 (01) : 23 - 37
  • [10] RELEASE OF CYTOPLASMIC FRAGMENTS AFTER RE-OXYGENATION OF HYPOXIC LIVER
    LEMASTERS, JJ
    STEMKOWSKI, CJ
    JI, S
    THURMAN, RG
    JOURNAL OF CELL BIOLOGY, 1982, 95 (02): : 110 - 110